Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Friday, May 2 • 6:00am - 7:30am
Persistent and Breakthrough Pain Individualizing Opioid Therapy for Fluctuating Cancer Pain

Sign up or log in to save this to your schedule and see who's attending!

This evidence-based best-practices program will foster discussion and debate among experts dedicated to improving the care of patients with cancer pain. Using brief summary didactics, peer-to-peer conversations, and case studies shaped by audience input, three recognized thought leaders in the field—each with established expertise in the diagnosis and individualized treatment of various cancer pain syndromes—will participate in an interactive, case-based discussion. The expert panel will share interpretive insights into practice guidelines as well as their own clinical strategies for assessing and differentially diagnosing breakthrough pain (BTP).

Recommendations for optimizing opioid-based therapy in diverse patient types and the class-wide Risk Evaluation and Mitigation Strategy for transmucosal immediate-release fentanyl medications will be addressed. Clinical cases will address pressing, real-world issues faced by oncology nurses, while incorporating reviews of patient-directed educational resources, self-management tips, and caregiver-support strategies. Register here.

This activity is supported by an educational grant from Teva CNS.

Speakers
MR

Michelle Rhiner, MSN, NP

Instructor, Family Practice, Loma Linda University School of Medicine
NE

Neal E. Slatkin, MD

Chief Medical Officer and Vice President of Medical Services, Hospice of the Valley
AH

April Hazard Vallerand, PhD, RN, FAAN

Professor, Wayne State University College of Nursing


Friday May 2, 2014 6:00am - 7:30am
Marquis Ballroom Center Anaheim Marriott Hotel, 700 W. Convention Way, Anaheim, CA 92802